NCT02394925 is a NA clinical trial of Multifocal Test Contact lens in Vision Correction, sponsored by Johnson & Johnson Vision Care, Inc..

Who is sponsoring NCT02394925?

NCT02394925 is sponsored by Johnson & Johnson Vision Care, Inc..

What drugs are being tested in NCT02394925?

Interventions in NCT02394925: Multifocal Test Contact lens.

What condition does NCT02394925 study?

NCT02394925 studies Vision Correction.

Is NCT02394925 still recruiting?

NCT02394925 is currently completed. Last updated 19 June 2018.

Are results published for NCT02394925?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-06-19 · How we verify

NCT02394925

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes

Completed NA Results posted Last updated 19 June 2018

What this trial tests

NA trial testing Multifocal Test Contact lens in Vision Correction in 113 participants. Completed in 1 September 2015.

Timeline

1 January 2015

Primary endpoint
1 September 2015

1 September 2015

Quick facts

Lead sponsor	Johnson & Johnson Vision Care, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	113
Start date	1 January 2015
Primary completion	1 September 2015
Estimated completion	1 September 2015
Sites	2 locations across United Kingdom, United States

Drugs / interventions tested

Multifocal Test Contact lens

Conditions studied

Vision Correction — all drugs for Vision Correction →

Sponsor

Johnson & Johnson Vision Care, Inc. — full company profile →

Who can join

Adults 40 to 70, any sex, with Vision Correction. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Proportion of Successful Contact Lens Wearers Primary · 2 months post wear

Proportion of Successful contact lens wearers is based on a subject's responses to two questionnaire items, "Overall Quality of Vision" and "Overall Comfort". Each item uses a 6 response like-rt scale (0= Not Applicable, 1=Excellent, 2=Very Good, 3=Good, 4=Fair and 5=Poor). The data from each item was dichotomized into two groups. If a subject responded "Excellent", "Very Good" or "Good" then the response=1, otherwise the response=0. The proportion of subjects with response=1 was reported as the proportion of successful contact lens wearers.

Group	Value	95% CI
Etafilcon -PVP (Multi-focal)	0.71

Sponsor's own description

The primary objective of this study is to determine the retention rate over a two month period of vision correction in emmetropic, presbyopes fitted with multifocal contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Vision Care, Inc. trials

Trials by the same sponsor.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07174596 — Evaluation of Approved Contact Lenses · NA · completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses · NA · completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process · NA · completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02394925 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 19 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02394925.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing